Investment Services
Finance
Biotechnology

PDL BioPharma

$3.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-2.18%) Today
$0.00 (0.00%) As of 4:08 PM EDT after-hours

Why Robinhood?

You can buy or sell PDL BioPharma and other stocks, options, ETFs, and crypto commission-free!

About PDLI

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. Read More The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. The Pharmaceutical segment covers revenues from branded prescription medicine products being sold under the name Tekturna and Tekturna HCT in the United States, and Rasilez and Rasilez HCT for the rest of the world. The Medical Devices segment handles revenues from the LENSAR Laser System sales. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Employees
105
Headquarters
Incline Village, Nevada
Founded
1986
Market Cap
387.53M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
734.48K
High Today
$3.25
Low Today
$3.14
Open Price
$3.18
Volume
755.05K
52 Week High
$3.89
52 Week Low
$2.25

Collections

Investment Services
Finance
Biotechnology
Biopharmaceutical
Pharmaceutical
Health

PDLI Earnings

$0.01
$0.06
$0.11
$0.16
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.